Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Decrease in arterial ketone body ratio indicating graft dysfunction after liver transplantation.

Y Takada1, Y Shimahara, D Manaka

  • 1Second Department of Surgery, Faculty of Medicine, Kyoto University, Japan.

The European Journal of Surgery = Acta Chirurgica
|May 1, 1992
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genome-wide DNA methylation status as a biomarker for clinical outcomes of first-line treatment in patients with RAS wild-type metastatic colorectal cancer: JACCRO CC-13AR.

ESMO open·2025
Same author

Ramucirumab plus FOLFIRI as second-line treatment for patients with RAS wild-type metastatic colorectal cancer previously treated with anti-EGFR antibody: JACCRO CC-16.

ESMO open·2023
Same author

Large-scale prospective genome-wide association study of oxaliplatin in stage II/III colon cancer and neuropathy.

Annals of oncology : official journal of the European Society for Medical Oncology·2021
Same author

Phase II study of trifluridine/tipiracil plus bevacizumab by RAS mutation status in patients with metastatic colorectal cancer refractory to standard therapies: JFMC51-1702-C7.

ESMO open·2021
Same author

Oxaliplatin-based adjuvant chemotherapy duration (3 versus 6 months) for high-risk stage II colon cancer: the randomized phase III ACHIEVE-2 trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2020
Same author

Large-scale prospective pharmacogenomics study of oxaliplatin-induced neuropathy in colon cancer patients enrolled in the JFMC41-1001-C2 (JOIN Trial).

Annals of oncology : official journal of the European Society for Medical Oncology·2016

Arterial ketone body ratio (AKBR) monitoring detected graft dysfunction faster than other tests in liver transplant patients. This ratio offers a sensitive indicator for early postoperative management after liver transplantation.

Area of Science:

  • Transplantation Medicine
  • Biochemistry
  • Surgical Monitoring

Background:

  • Living related liver transplantation is a complex procedure requiring vigilant postoperative monitoring.
  • Assessing graft function early is critical for patient outcomes.
  • Traditional liver function tests may have limitations in sensitivity and speed.

Observation:

  • In three cases of living related liver transplantation, a secondary decrease in arterial ketone body ratio (AKBR) was observed.
  • This decrease occurred within the early postoperative period.

Findings:

  • The arterial ketone body ratio (AKBR) demonstrated a more rapid and sensitive indication of graft dysfunction compared to other standard liver function tests.
  • AKBR changes provided an earlier warning signal for potential graft issues.

Related Experiment Videos

Implications:

  • The arterial ketone body ratio (AKBR) shows significant potential as a key biomarker for monitoring graft health post-liver transplantation.
  • Integrating AKBR monitoring into postoperative care protocols could improve graft survival rates.
  • Further research is warranted to validate AKBR's role in diverse liver transplant scenarios.